Drug updated on 3/28/2024
Dosage Form | Tablet (oral; 2 mg) |
Drug Class | Antihelminthics |
Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- Moxidectin is indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older.
Product Monograph / Prescribing Information
Document Title | Year | Source |
---|---|---|
Moxidectin (moxidectin) Prescribing Information. | 2021 | Medicines Development for Global Health, Melbourne, Victoria, Australia |
Systematic Reviews / Meta-Analyses
Document Title | Year | Source |
---|---|---|
Can moxidectin be an anthelmintic alternative for trichuris trichiura and strongyloides stercoralis: a systematic review. | 2022 | Cureus |
A systematic review of moxidectin as a treatment for parasitic infections in mammalian species. | 2021 | Parasitology Research |